Daniela E Matei (Daniela Matei)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Cancer Stem Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum through Nicotinamide N-methyltransferase. Molecular cancer therapeutics (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Russell Keathley, Masha Kocherginsky, Ramana Davuluri, Daniela E Matei
Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer. Cancers 15 (14) (2023)
Yuying Tan, Junjie Li, Guangyuan Zhao, Kai-Chih Huang, Horacio Cardenas, Yinu Wang, Daniela E Matei, Ji-Xin Cheng
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nature communications 13 (1) (2022)
Livia Elena Sima, Daniela E Matei, Salvatore Condello
The Outside-In Journey of Tissue Transglutaminase in Cancer. Cells 11 (11) (2022)
Guangyuan Zhao, Yuying Tan, Horacio Cardenas, David Vayngart, Yinu Wang, Hao Huang, Russell Keathley, Jian-Jun Wei, Christina R Ferreira, Sandra Orsulic, Ji-Xin Cheng, Daniela E Matei
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids. Proceedings of the National Academy of Sciences of the United States of America 119 (41) (2022)
Yaqi Zhang, Yinu Wang, Andres Felipe Valdivia, Hao Huang, Daniela E Matei
DOT1L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling. Molecular cancer research : MCR (2022)
Dario R Roque, Daniela E Matei
Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Monal Patel, Yinu Wang, Elizabeth Thomas Bartom, Rohin Dhir, Kenneth P Nephew, Daniela E Matei, Andrea E Murmann, Ernst Lengyel, Marcus E Peter
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer. Cancer research 81 (15) (2021)
Horacio Cardenas, Fang Fang, Guanglong Jiang, Susan M Perkins, Chi Zhang, Robert E Emerson, George Hutchins, Harold N Keer, Yunlong Liu, Daniela E Matei, Kenneth Nephew
Methylomic Signatures of High Grade Serous Ovarian Cancer. Epigenetics 16 (11) (2020)
Yinu Wang, Guangyuan Zhao, Salvatore Condello, Hao Huang, Horacio Cardenas, Edward J Tanner, JianJun Wei, Yanrong Ji, Junjie Li, Yuying Tan, Ramana V Davuluri, Marcus E Peter, Ji-Xin Cheng, Daniela E Matei
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis. Cancer research 81 (2) (2020)
E Gabriela Chiorean, Susan M Perkins, R Matthew Strother, Anne Younger, Jennifer M Funke, Safi G Shahda, Noah M Hahn, Kumar Sandrasegaran, David R Jones, Todd C Skaar, Bryan P Schneider, Christopher J Sweeney, Daniela E Matei
Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors. Molecular cancer therapeutics 19 (10) (2020)
Guangyuan Zhao, Horacio Cardenas, Daniela E Matei
Ovarian Cancer-Why Lipids Matter. Cancers 11 (12) (2019)
Justin Lathia, Huiping Liu, Daniela E Matei
The Clinical Impact of Cancer Stem Cells. The oncologist (2019)
Nkechiyere G Nwani, Salvatore Condello, Yinu Wang, Wendy M Swetzig, Emma Barber, Thomas Hurley, Daniela E Matei
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer. Cancers 11 (4) (2019)
Justin Lathia, Huiping Liu, Daniela E Matei
The Clinical Impact of Cancer Stem Cells. The oncologist 25 (2) (2019)